CSRXP: WHITE HOUSE FRAMEWORK FAILS ON PROMISE TO LOWER DRUG PRICES
Oct 28, 2021
Framework Fails to Hold Big Pharma Accountable and Lower Drug Prices for the… Read More
© 2024 CSRXP- All Rights Reserved
Press & Statements
CSRXP WELCOMES FDA APPROVAL OF FIRST INTERCHANGEABLE BIOSIMILAR FOR HUMIRA AS POSITIVE FIRST STEP
Oct 20, 2021
U.S. Food & Drug Administration Approval of Cyltezo Marks Second… Read More
CSRXP ENCOURAGES HOUSE JUDICIARY COMMITTEE TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE
Sep 29, 2021
Committee Mark Up Targets Brand Name Drug Companies’ Anti-Competitive… Read More
CSRXP POLL: MASSIVE MAJORITIES OF AMERICAN VOTERS SUPPORT SOLUTIONS TO LOWER DRUG PRICES AND HOLD BIG PHARMA ACCOUNTABLE
Sep 14, 2021
Americans Blame Big Pharma for Out-of-Control Drug Prices, Reject Bogus… Read More
CSRXP: HOUSE MARKUPS ADD TO UNPRECEDENTED MOMENTUM TO HOLD BIG PHARMA ACCOUNTABLE
Sep 14, 2021
Committee Leaders Put Forward Solutions to Lower Prescription Drug Prices for… Read More
CSRXP APPLAUDS RELEASE OF HHS PLAN TO LOWER PRESCRIPTION DRUG PRICES AND HOLD BIG PHARMA ACCOUNTABLE
Sep 9, 2021
Administration Proposal Would Increase Competition, Transparency and Value —… Read More
CSRXP APPLAUDS PRESIDENT BIDEN’S COMMITMENT TO LOWERING PRESCRIPTION DRUG PRICES AND CALL FOR CONGRESS TO ACT
Aug 12, 2021
Speech Adds to Unprecedented Momentum for Action, Now Lawmakers Must Deliver… Read More
CSRXP STATEMENT ON U.S. SENATE PASSAGE OF REBATE RULE DELAY & REFUND ACT AS PART OF BIPARTISAN INFRASTRUCTURE BILL
Aug 10, 2021
Lawmakers Must Build on Momentum For Action With Permanent Repeal of Rebate… Read More
CSRXP WELCOMES FDA APPROVAL OF FIRST INTERCHANGEABLE BIOLOGIC FOR INSULIN
Jul 29, 2021
Interchangeable Products Will Help Increase Prescription Drug Competition and… Read More
CSRXP: SENATE JUDICIARY COMMITTEE CRACKS DOWN ON BIG PHARMA PATENT ABUSE
Jul 29, 2021
Unanimous, Bipartisan Passage of Bills Targeting Brand Name Drug Companies’… Read More
CSRxP COMMENDS PRESIDENT BIDEN FOR RENEWED COMMITMENT TO HOLDING BIG PHARMA ACCOUNTABLE
Jul 9, 2021
Campaign Looks Forward to Working with Administration and Congress to Crack… Read More
CSRXP: OVERSIGHT REPORT ADDS TO MOMENTUM IN WASHINGTON TO HOLD BIG PHARMA ACCOUNTABLE
Jul 8, 2021
U.S. House Oversight & Reform Committee Report Shines Light on Branded… Read More